FLERIE Stock Overview
Flerie Invest AB is a venture capital firm specializing in early-stage investments.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
Flerie AB (publ) Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | kr0.50 |
52 Week High | kr0.57 |
52 Week Low | kr0.50 |
Beta | 0 |
11 Month Change | n/a |
3 Month Change | n/a |
1 Year Change | n/a |
33 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -7.25% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
FLERIE | SE Pharmaceuticals | SE Market | |
---|---|---|---|
7D | -2.9% | 0.4% | -0.7% |
1Y | n/a | 82.5% | 16.6% |
Return vs Industry: Insufficient data to determine how FLERIE performed against the Swedish Pharmaceuticals industry.
Return vs Market: Insufficient data to determine how FLERIE performed against the Swedish Market.
Price Volatility
FLERIE volatility | |
---|---|
FLERIE Average Weekly Movement | n/a |
Pharmaceuticals Industry Average Movement | 10.0% |
Market Average Movement | 5.9% |
10% most volatile stocks in SE Market | 12.7% |
10% least volatile stocks in SE Market | 3.5% |
Stable Share Price: FLERIE has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine FLERIE's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2011 | n/a | Ted Fjallman | www.flerie.com |
Flerie Invest AB is a venture capital firm specializing in early-stage investments. It seeks to invest in biotech and pharma companies engaged in drug development and associated tools or applications tackling major medical challenges of our time. The firm seeks to invest in Europe, United States and Israel.
Flerie AB (publ) Fundamentals Summary
FLERIE fundamental statistics | |
---|---|
Market cap | kr3.81b |
Earnings (TTM) | kr0 |
Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs FLERIE overvalued?
See Fair Value and valuation analysisEarnings & Revenue
FLERIE income statement (TTM) | |
---|---|
Revenue | kr0 |
Cost of Revenue | kr0 |
Gross Profit | kr0 |
Other Expenses | kr0 |
Earnings | kr0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
Earnings per share (EPS) | 0 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 0.0% |
How did FLERIE perform over the long term?
See historical performance and comparison